Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Devi, Nandana"'
Autor:
Friedrich Stölzel, Sarah E. Fordham, Devi Nandana, Wei-Yu Lin, Helen Blair, Claire Elstob, Hayden L. Bell, Brigitte Mohr, Leo Ruhnke, Desiree Kunadt, Claudia Dill, Daniel Allsop, Rachel Piddock, Emmanouela-Niki Soura, Catherine Park, Mohd Fadly, Thahira Rahman, Abrar Alharbi, Manja Wobus, Heidi Altmann, Christoph Röllig, Lisa Wagenführ, Gail L. Jones, Tobias Menne, Graham H. Jackson, Helen J. Marr, Jude Fitzgibbon, Kenan Onel, Manja Meggendorfer, Amber Robinson, Zuzanna Bziuk, Emily Bowes, Olaf Heidenreich, Torsten Haferlach, Sara Villar, Beñat Ariceta, Rosa Ayala Diaz, Steven J. Altschuler, Lani F. Wu, Felipe Prosper, Pau Montesinos, Joaquin Martinez-Lopez, Martin Bornhäuser, James M. Allan
Publikováno v:
JCI Insight, Vol 8, Iss 2 (2023)
Precision medicine can significantly improve outcomes for patients with cancer, but implementation requires comprehensive characterization of tumor cells to identify therapeutically exploitable vulnerabilities. Here, we describe somatic biallelic TET
Externí odkaz:
https://doaj.org/article/099cf4b757194708b07592874d0436b2
Autor:
Devi, Nandana1, Nagesh, A. Muni1, Jala, Moses Azaraiah1, Gupta, Surabhi1, Chaturvedi, Pradeep Kumar1, Kumar, Neeraj1, Sandeep, Kumar2, Pandey, Deepak1 deepak4jul@gmail.com
Publikováno v:
Indian Journal of Natural Products & Resources. Mar2023, Vol. 14 Issue 1, p28-36. 9p.
Autor:
Devi Nandana
Publikováno v:
China Report. 58:362-364
Rush Doshi, The Long Game: China’s Grand Strategy to Displace American Order (Oxford University Press, New York, USA, 2021), pp. 336, ISBN: 978-0197527917.
Autor:
Friedrich, Stölzel, Sarah E, Fordham, Devi, Nandana, Wei-Yu, Lin, Helen J, Blair, Claire J, Elstob, Hayden L, Bell, Brigitte, Mohr, Leo, Ruhnke, Desiree, Kunadt, Claudia, Dill, Daniel A, Allsop, Rachel E, Piddock, Emmanouela-Niki, Soura, Catherine Vida, Park, Mohd, Fadly, Thahira, Rahman, Abrar A, Alharbi, Manja, Wobus, Heidi, Altmann, Christoph, Röllig, Lisa, Wagenführ, Gail L, Jones, Tobias, Menne, Graham H, Jackson, Helen J, Marr, Jude, Fitzgibbon, Kenan, Onel, Manja, Meggendorfer, Amber, Robinson, Zuzanna, Bziuk, Emily, Bowes, Olaf, Heidenreich, Torsten, Haferlach, Sara, Villar, Beñat, Ariceta, Rosa, Ayala Diaz, Steven J, Altschuler, Lani, Wu, Felipe, Prosper, Pau, Montesinos, Joaquin, Martinez-Lopez, Martin, Bornhäuser, James M, Allan
Publikováno v:
JCI insight.
Precision medicine can significantly improve outcomes for cancer patients, but implementation requires comprehensive characterization of tumor cells to identify therapeutically exploitable vulnerabilities. Here we describe somatic biallelic TET2 muta
Autor:
Rachel Piddock, Claire Elstob, Abrar Alharbi, Emmanouela-Niki Soura, Graham Jackson, Joaquin Martinez-Lopez, Gail Jones, Tobias Menne, Brigitte Mohr, James M. Allan, Desiree Kunadt, Helen J. Blair, Jude Fitzgibbon, Christoph Röllig, Heidi Altmann, Claudia Dill, Leo Ruhnke, Manja Meggendorfer, Lisa Wagenführ, Olaf Heidenreich, Helen Marr, Sarah E. Fordham, Thahira Rahman, Kenan Onel, Mohd Fadly, Martin Bornhäuser, Torsten Haferlach, Friedrich Stölzel, Beñat Ariceta, Pau Montesinos, Wei-Yu Lin, Felipe Prosper, Catherine Park, Rosa Ayala Diaz, Devi Nandana, Daniel Allsop, Sara Villar, Manja Wobus
Precision medicine can significantly improve outcomes for cancer patients, but implementation requires comprehensive characterization of tumor cells to identify therapeutically exploitable vulnerabilities. Here we describe somatic biallelic TET2 muta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bce312283fde11cc321c74be561c80ff
https://doi.org/10.1101/2021.07.14.21259597
https://doi.org/10.1101/2021.07.14.21259597
Autor:
Torsten Haferlach, Manja Meggendorfer, Kenan Onel, Mohd Fadly, Emmanouela-Niki Soura, Manja Wobus, Daniel Allsop, Helen J. Blair, Sarah E. Fordham, Claire Elstob, Thahira Rahman, Martin Bornhäuser, Devi Nandana, Catherine Park, Gail Jones, Desiree Kunadt, Olaf Heidenreich, Tobias Menne, Wei-Yu Lin, Helen Marr, Friedrich Stoelzel, Brigitte Mohr, Leo Ruhnke, Graham Jackson, James M. Allan, Heidi Altmann
Publikováno v:
Blood. 134:113-113
Personalised medicine is predicted to significantly improve outcomes for cancer patients, but implementation requires comprehensive genetic characterisation of malignant cells to identify therapeutically exploitable vulnerabilities. Using an isogenic